UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Precision Medicine: From Science To Value

Health Affairs, 2018-05, Vol.37 (5), p.694-701

2018

Volltextzugriff (PDF)

Availability and funding of clinical genomic sequencing globally

BMJ global health, 2021-02, Vol.6 (2), p.e004415

2021

Volltextzugriff (PDF)

Assessing the Value and Implications of Personalized/Precision Medicine and the “Lessons Learned” for Emerging Technologies: An Introduction

Value in health, 2017, Vol.20 (1), p.30-31

Phillips, Kathryn A., PhD

2017

Volltextzugriff (PDF)

Evolving Payer Coverage Policies on Genomic Sequencing Tests: Beginning of the End or End of the Beginning?

JAMA : the journal of the American Medical Association, 2018-06, Vol.319 (23), p.2379

Phillips, Kathryn A.

2018

Volltextzugriff (PDF)

Strongyloides Infections of Humans and Great Apes in Dzanga-Sangha Protected Areas, Central African Republic and in Degraded Forest Fragments in Bulindi, Uganda

Parasitology international, 2016-10, Vol.65 (5), p.367-370

2016

Volltextzugriff (PDF)

Potential savings from substituting generic drugs for brand-name drugs: medical expenditure panel survey, 1997-2000

Annals of internal medicine, 2005-06, Vol.142 (11), p.891

2005

Volltextzugriff (PDF)

Genetic Test Availability And Spending: Where Are We Now? Where Are We Going?

Health Affairs, 2018-05, Vol.37 (5), p.710-716

2018

Volltextzugriff (PDF)

Methods for Moving the Evaluation of Precision Medicine Into Practice and Policy

Value in health, 2020-05, Vol.23 (5), p.527-528

Phillips, Kathryn A.

2020

Volltextzugriff (PDF)

“What Goes Around Comes Around”: Lessons Learned from Economic Evaluations of Personalized Medicine Applied to Digital Medicine

Value in health, 2017, Vol.20 (1), p.47-53

2017

Volltextzugriff (PDF)

Open Access Publication at a Crossroads-Implications for Researchers and Beyond

JAMA health forum, 2024-10, Vol.5 (10), p.e242914

Phillips, Kathryn A

2024

Volltextzugriff (PDF)

Measuring Patient Preferences for Colorectal Cancer Screening Using a Choice-Format Survey

Value in health, 2007-09, Vol.10 (5), p.415-430

2007

Volltextzugriff (PDF)

Decision Making on Medical Innovations in a Changing Health Care Environment: Insights from Accountable Care Organizations and Payers on Personalized Medicine and Other Technologies

Value in health, 2017, Vol.20 (1), p.40-46

2017

Volltextzugriff (PDF)

Assessing the Value of Next-Generation Sequencing Technologies: An Introduction

Value in health, 2018-09, Vol.21 (9), p.1031-1032

Phillips, Kathryn A.

2018

Volltextzugriff (PDF)

User characteristics and out-of-pocket expenditures for progestin-only versus combined oral contraceptives

Contraception (Stoneham), 2012-12, Vol.86 (6), p.666-672

2012

Volltextzugriff (PDF)

The State of State Biomarker Testing Insurance Coverage Laws

JAMA : the journal of the American Medical Association, 2024-06, Vol.331 (22), p.1885

2024

Volltextzugriff (PDF)

State Biomarker Testing Insurance Coverage Laws—Reply

JAMA : the journal of the American Medical Association, 2024-09, Vol.332 (14), p.1208

2024

Volltextzugriff (PDF)

Eligibility criteria in private and public coverage policies for BRCA genetic testing and genetic counseling

Genetics in medicine, 2011-12, Vol.13 (12), p.1045-1050

2011

Volltextzugriff (PDF)

CMS Coverage With Evidence Development-Challenges and Opportunities for Improvement

JAMA health forum, 2022-09, Vol.3 (9), p.e223061-e223061

Phillips, Kathryn A

2022

Volltextzugriff (PDF)

Strategies to identify the Lynch syndrome among patients with colorectal cancer: a cost-effectiveness analysis

Annals of internal medicine, 2011-07, Vol.155 (2), p.69

2011

Volltextzugriff (PDF)

Clinical practice patterns and cost effectiveness of human epidermal growth receptor 2 testing strategies in breast cancer patients

Cancer, 2009-11, Vol.115 (22), p.5166-5174

2009

Volltextzugriff (PDF)

Expanding Use of Clinical Genome Sequencing and the Need for More Data on Implementation

JAMA : the journal of the American Medical Association, 2020-11, Vol.324 (20), p.2029

2020

Volltextzugriff (PDF)

Multicancer Screening Tests: Anticipating And Addressing Considerations For Payer Coverage And Patient Access

Health affairs (Millwood, Va.), 2022-03, Vol.41 (3), p.383-2

2022

Volltextzugriff (PDF)

Use of Real-World Evidence in US Payer Coverage Decision-Making for Next-Generation Sequencing–Based Tests: Challenges, Opportunities, and Potential Solutions

Value in health, 2020-05, Vol.23 (5), p.540-550

2020

Volltextzugriff (PDF)

Emergence of Hybrid Models of Genetic Testing Beyond Direct-to-Consumer or Traditional Labs

JAMA : the journal of the American Medical Association, 2019-06, Vol.321 (24), p.2403

2019

Volltextzugriff (PDF)

Personalized medicine and oncology practice guidelines: a case study of contemporary biomarkers in colorectal cancer

Journal of the National Comprehensive Cancer Network, 2011-01, Vol.9 (1), p.13-25

2011

Volltextzugriff (PDF)

1 – 25 von 1.476

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.322)
Mit Volltextzugriff
(1.174)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(985)
Life Sciences & Biomedicine
(940)
Humans
(508)
Female
(301)
Biology
(295)
Life Sciences & Biomedicine - Other Topics
(290)
Male
(227)
Adult
(144)
Middle Aged
(123)
Biological And Medical Sciences
(111)
United States
(106)
Social Sciences
(103)
Animals
(94)
Aged
(92)
Health Care Sciences & Services
(91)
Medical Sciences
(90)
General & Internal Medicine
(87)
Medicine, General & Internal
(79)
Adolescent
(77)
Health Policy & Services
(72)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(6)
... seit 90 Tagen
(14)

Menü

Weitere Dienste

Einstellungen

Precision Medicine: From Science To Value

Availability and funding of clinical genomic sequencing globally

Assessing the Value and Implications of Personalized/Precision Medicine and the “Lessons Learned” for Emerging Technologies: An Introduction

Evolving Payer Coverage Policies on Genomic Sequencing Tests: Beginning of the End or End of the Beginning?

Strongyloides Infections of Humans and Great Apes in Dzanga-Sangha Protected Areas, Central African Republic and in Degraded Forest Fragments in Bulindi, Uganda

Potential savings from substituting generic drugs for brand-name drugs: medical expenditure panel survey, 1997-2000

Genetic Test Availability And Spending: Where Are We Now? Where Are We Going?

Methods for Moving the Evaluation of Precision Medicine Into Practice and Policy

“What Goes Around Comes Around”: Lessons Learned from Economic Evaluations of Personalized Medicine Applied to Digital Medicine

Open Access Publication at a Crossroads-Implications for Researchers and Beyond

Measuring Patient Preferences for Colorectal Cancer Screening Using a Choice-Format Survey

Decision Making on Medical Innovations in a Changing Health Care Environment: Insights from Accountable Care Organizations and Payers on Personalized Medicine and Other Technologies

Assessing the Value of Next-Generation Sequencing Technologies: An Introduction

User characteristics and out-of-pocket expenditures for progestin-only versus combined oral contraceptives

The State of State Biomarker Testing Insurance Coverage Laws

State Biomarker Testing Insurance Coverage Laws—Reply

Eligibility criteria in private and public coverage policies for BRCA genetic testing and genetic counseling

CMS Coverage With Evidence Development-Challenges and Opportunities for Improvement

Strategies to identify the Lynch syndrome among patients with colorectal cancer: a cost-effectiveness analysis

Clinical practice patterns and cost effectiveness of human epidermal growth receptor 2 testing strategies in breast cancer patients

Expanding Use of Clinical Genome Sequencing and the Need for More Data on Implementation

Multicancer Screening Tests: Anticipating And Addressing Considerations For Payer Coverage And Patient Access

Use of Real-World Evidence in US Payer Coverage Decision-Making for Next-Generation Sequencing–Based Tests: Challenges, Opportunities, and Potential Solutions

Emergence of Hybrid Models of Genetic Testing Beyond Direct-to-Consumer or Traditional Labs

Personalized medicine and oncology practice guidelines: a case study of contemporary biomarkers in colorectal cancer

Suchergebnisse filtern